首页> 外文会议>International Congress on Neuropathic Pain >Can we create placebo responders and non-responders in the lab?
【24h】

Can we create placebo responders and non-responders in the lab?

机译:我们可以在实验室创建安慰剂响应者和非响应者吗?

获取原文

摘要

The recent advances in placebo research have uncovered many mechanisms through both the psychological and neurobiological approach, with a number of important clinical implications (Benedetti, 2008; Price et al., 2008; Enck et al., 2008; Finniss et al., 2010). Indeed, some of these mechanisms can be exploited in clinical trials as well as in medical practice, although the objectives are certainly opposite in the two situations. In fact, whereas placebo responses need to be reduced in clinical trials, their increase is desirable in routine medical practice. With this in mind, today we are in a good position to consider the possibility to manipulate placebo responses in both directions in order to create either placebo responders or non-responders in the laboratory. However, it is important to remember that the improvement that may take place in a patient who has received a placebo may depend on plenty of factors, such as spontaneous remission, regression to the mean, experimenter's and patient's biases, and the like. By keeping all these factors constant, the real placebo response, i.e. the real psychobiological phenomenon, can be manipulated and/or controlled in a number of ways.
机译:最近安慰剂研究的进展通过心理和神经生物学方法揭示了许多机制,具有许多重要的临床意义(Benedetti,2008; Price等,2008; Enck等,2008; Finniss等,2010 )。实际上,一些机制可以在临床试验以及医学实践中被利用,尽管目标肯定在两种情况下恰到好。事实上,在临床试验中需要减少安慰剂反应,因此在常规医疗实践中可以获得它们的增加。考虑到这一点,今天我们处于一个良好的位置,以考虑操纵两个方向的安慰剂回应的可能性,以便在实验室中创建安慰剂响应者或非响应者。然而,重要的是要记住,在收到安慰剂的患者中可能发生的改进可能取决于大量因素,例如自发缓解,对平均值,实验者和患者的偏见等的回归等。通过保持所有这些因素常数,可以以多种方式操纵和/或控制真正的安慰剂响应,即真正的精神病学现象。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号